Thymosin Beta-4 synthetic fragment. Studied for its role in tissue repair, angiogenesis, and recovery from musculoskeletal injury. Physician-reviewed. Prescription required.
TB-500 is a synthetic version of a naturally occurring peptide fragment derived from Thymosin Beta-4. It is primarily studied for tissue repair, anti-inflammatory effects, angiogenesis, and cytoskeletal regulation. Unlike receptor-specific drugs, TB-500 acts through multiple cellular processes related to actin dynamics, cell migration, and tissue regeneration.
Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Result |
|---|---|
| Actin binding | Increased cell migration and repair |
| Angiogenesis | New blood vessel formation |
| Anti-inflammatory signaling | Reduced tissue inflammation |
| Stem cell recruitment | Regeneration of damaged tissue |
| Anti-apoptotic pathways | Increased cell survival |
| ECM remodeling | Reduced fibrosis |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with TB-500 protocol candidates in clinical practice:
Musculoskeletal Recovery
Individuals recovering from tendon, ligament, or muscle injuries seeking physician-supervised recovery support.
Post-Surgical Healing
Individuals post-orthopedic or soft tissue surgery where tissue repair support may be clinically appropriate.
Athletic Performance
High-output athletes managing accumulated strain and soft tissue wear requiring physician-supervised support.
Combination Recovery Stack
Patients combining TB-500 with BPC-157 in a physician-reviewed dual-recovery protocol.
Determine your candidacy
A physician will review your intake and make eligibility determination within 24–48 hours.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.
Typical Range
2.0–5.0 mg/week
Administration
Subcutaneous injection
Duration
4–12 weeks (physician-determined)
Frequency
1–2x weekly (physician-determined)
These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility.
Begin your TB-500 protocol.
Complete your intake. Physician review within 24–48 hours.
Physician-reviewed. Pharmacy-dispensed. Prescription required before any order is fulfilled.
Prescription required. Results may vary. Individual outcomes may differ.
TB-500 helps with muscle tears, tendon injuries, ligament damage, joint inflammation, and post-surgical healing. Unlike BPC-157 which works locally, TB-500 has systemic healing effects.
Standard TB-500 cycles are 4-6 weeks. For chronic injuries, some patients extend to 8 weeks under physician guidance.
No. BPC-157 is best for local targeted repair. TB-500 works systemically. They are frequently stacked together for comprehensive healing coverage.
Most patients notice reduced pain and inflammation within 2-3 weeks. Full tissue healing benefits develop over the complete cycle.